ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,308.13
      0.00%
      US Tech 100
      18,140.80
      -0.31%
      Dow Jones
      39,806.77
      0.00%
      Brent Oil
      82.455
      -1.29%
      Bitcoin
      70,992.92
      -0.64%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Centessa Pharmaceuticals PLC (CNTA)

      7. Centessa Pharmaceuticals PLC (CNTA) News

      CNTA Centessa Pharmaceuticals PLC

      8.72
      0.00 (0.00%)
      Pre Market
      Last Updated: 09:02:39
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Centessa Pharmaceuticals PLC CNTA NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 8.72 09:02:39
      Open Price Low Price High Price Close Price Prev Close
      8.72
      more quote information »

      Recent News

      Date Time Source Heading
      5/21/202408:45GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
      5/13/202416:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      5/13/202416:23EDGAR2Form 8-K - Current report
      5/13/202416:10GLOBECentessa Pharmaceuticals Reports Financial Results and..
      5/09/202408:01EDGAR2Form ARS - Annual Report to Security Holders
      5/09/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
      4/23/202421:36GLOBECentessa Pharmaceuticals Announces Pricing of $100 Million..
      4/23/202416:17GLOBECentessa Pharmaceuticals Announces $100 Million Proposed..
      4/22/202407:00GLOBECentessa Pharmaceuticals Announces Open IND for ORX750;..
      3/28/202416:28GLOBECentessa Pharmaceuticals Reports Business Highlights and..
      2/22/202408:00GLOBECentessa Pharmaceuticals to Participate in TD Cowen’s 44th..
      2/09/202407:12EDGAR2Form 8-K - Current report
      2/09/202407:00GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
      2/02/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/01/202416:07EDGAR2Form 144 - Report of proposed sale of securities
      1/22/202408:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
      1/09/202407:56EDGAR2Form 8-K - Current report
      1/02/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202419:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/13/202308:00GLOBECentessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P...
      12/11/202307:05EDGAR2Form 8-K - Current report
      12/10/202312:05GLOBECentessa Pharmaceuticals Announces New Data from an..
      11/27/202316:15GLOBEAnaptys Expands Immune Cell Modulator Pipeline with..
      11/13/202316:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:17EDGAR2Form 8-K - Current report
      11/13/202316:05GLOBECentessa Pharmaceuticals Reports Financial Results and..
      11/02/202309:09GLOBECentessa Pharmaceuticals to Present Additional 52-Weeks of..
      10/31/202308:00GLOBECentessa Pharmaceuticals Announces Dosing of First Subject..
      10/30/202308:00GLOBECentessa Pharmaceuticals to Participate in Upcoming Investor..
      10/25/202309:49EDGAR2Form 8-K - Current report
      10/25/202308:00GLOBECentessa Pharmaceuticals Announces Preclinical Data..
      10/03/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/03/202308:00GLOBECentessa Pharmaceuticals Announces Additions to Senior..
      9/22/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/20/202316:02EDGAR2Form 144 - Report of proposed sale of securities
      9/01/202316:31EDGAR2Form 144 - Report of proposed sale of securities
      8/31/202308:00GLOBECentessa Pharmaceuticals to Participate in the Morgan..
      8/23/202317:08GLOBECentessa Pharmaceuticals to Present Preclinical Data for..
      8/14/202307:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      CNTA
      Centessa Pharmaceuticals
      LSE
      1064
      Delayed Upgrade Clock